Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune...

por Heinimäki, Suvi, Malm, Maria, Vesikari, Timo, Blazevic, Vesna
Publicado 2018

Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo

por Tamminen, Kirsi, Heinimäki, Suvi, Vesikari, Timo, Blazevic, Vesna
Publicado 2020

Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform

por Gröhn, Stina, Heinimäki, Suvi, Tamminen, Kirsi, Blazevic, Vesna
Publicado 2020

Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses

por Tamminen, Kirsi, Heinimäki, Suvi, Gröhn, Stina, Blazevic, Vesna
Publicado 2021

Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only

por Heinimäki, Suvi, Tamminen, Kirsi, Hytönen, Vesa P., Malm, Maria, Blazevic, Vesna
Publicado 2020

Modular vaccine platform based on the norovirus-like particle

por Lampinen, Vili, Heinimäki, Suvi, Laitinen, Olli H., Pesu, Marko, Hankaniemi, Minna M., Blazevic, Vesna, Hytönen, Vesa P.
Publicado 2021

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like partic...

por Leroux-Roels, Isabel, Maes, Cathy, Joye, Jasper, Jacobs, Bart, Jarczowski, Franziska, Diessner, André, Janssens, Yorick, Waerlop, Gwenn, Tamminen, Kirsi, Heinimäki, Suvi, Blazevic, Vesna, Leroux-Roels, Geert, Klimyuk, Victor, Adachi, Hiroshi, Hiruta, Kazuyuki, Thieme, Frank
Publicado 2022